Phase I clinical trial of oral 2-methoxyestradiol, an antiangiogenic and apoptotic agent, in patients with solid tumorsWilliam L. Dahut, William D. Figg, Allyson L. Parr et al.|Cancer Biology & Therapy|2006Cited by 155